Fig. 3From: Clinical utility of combined assessments of 4D volumetric perfusion CT, diffusion-weighted MRI and 18F-FDG PET-CT for the prediction of outcomes of head and neck squamous cell carcinoma treated with chemoradiotherapyROC curves demonstrating the differentiation of the predicted probabilities of progression-free survival for the significant predictors obtained from imaging parametersBack to article page